Central retinal artery occlusion is a sudden blockage of blood flow to the retina that causes painless, severe vision loss in one eye. People with central retinal artery occlusion often notice a sudden dark curtain or very blurry vision, and doctors may see a pale retina on exam. It is an emergency and can signal a higher risk of stroke, so urgent evaluation and treatment are needed. Treatment focuses on quickly restoring blood flow if possible and managing causes like cardiovascular disease, and vision recovery varies. Older adults and people with high blood pressure, diabetes, high cholesterol, or smoking history are most affected, and mortality relates to underlying vascular risks rather than the eye event itself.
Overview
Central retinal artery occlusionSymptoms
Central retinal artery occlusion usually causes sudden, painless, severe vision loss in one eye—often like a gray curtain or blackout. Colors may look faded and central detail can disappear. Some have brief, warning episodes of temporary one‑eye vision loss beforehand.
Outlook and prognosis
Many people with central retinal artery occlusion lose central vision in the affected eye quickly, and some have permanent blind spots. Faster treatment improves the chances of partial recovery. Ongoing eye care and stroke risk management help protect overall health.
Causes and risk factors
Central retinal artery occlusion often stems from an embolus or clot from carotid atherosclerosis or atrial fibrillation. Risks include age, smoking, hypertension, diabetes, high cholesterol, and giant cell arteritis. Inherited clotting disorders, antiphospholipid, and sickle cell disease raise risk.
Genetic influences
Genetics plays a limited role in central retinal artery occlusion; most cases relate to cardiovascular risk factors like atherosclerosis or emboli. Rarely, inherited clotting tendencies or lipid disorders raise risk. Family history matters mainly through shared blood pressure, cholesterol, or diabetes patterns.
Diagnosis
Central retinal artery occlusion is diagnosed clinically after sudden, painless vision loss, using a dilated eye exam that shows retinal whitening and a cherry‑red spot. Urgent tests—OCT, fluorescein angiography, and vascular stroke workup—help confirm and identify causes.
Treatment and drugs
Treatment focuses on urgent eye blood flow support and protecting the other eye. For central retinal artery occlusion, doctors may use pressure-lowering eye drops, ocular massage, breathing oxygen with carbon dioxide, and manage triggers like atrial fibrillation or carotid artery disease.
Symptoms
You may notice sudden, painless vision loss in one eye that makes it hard to read, recognize faces, or step off a curb. Early on, this might look like a brief gray curtain that lifts after a few minutes. For some, early symptoms of central retinal artery occlusion are these short episodes, which can be followed by more persistent loss.
Vision in one eye drops quickly, often within minutes to an hour. It is typically painless and can feel like a dark shade came down. This is common in central retinal artery occlusion.
The change usually affects just one eye. The other eye often sees normally, which can mask how severe the problem is.
Parts of your view can vanish, leaving a central or side blind area. Reading, faces, or steps may become hard to make out.
Vision can look gray, foggy, or washed out. Colors and contrast may seem dull in the affected eye.
How people usually first notice Central retinal artery occlusion?
Most people first notice central retinal artery occlusion as a sudden, painless loss of vision in one eye, sometimes described as a curtain or gray haze descending within seconds to minutes. Colors may look washed out and fine details vanish, and some notice brief “warning” episodes of vision dimming (amaurosis fugax) in the days or weeks before the permanent loss. In the clinic, doctors confirm CRAO by checking vision and pupils, then examining the retina for a pale inner layer with a cherry-red spot, which helps distinguish the first signs of central retinal artery occlusion from other eye emergencies.
Types of Central retinal artery occlusion
Central retinal artery occlusion (CRAO) has a few well-recognized clinical variants that influence how vision changes and what doctors see on exam. These variants reflect whether the main artery or smaller branches are blocked, whether a temporary blockage occurred, and whether a cilioretinal artery helps spare central vision. Not everyone will experience every type. When people talk about types of CRAO, they often mean one of these patterns seen on exam and in day-to-day vision changes.
Non-arteritic CRAO
Sudden, painless, severe vision loss in one eye, often noticed on waking or during daily tasks. Usually linked to a clot or plaque traveling from the neck or heart. Early symptoms of central retinal artery occlusion can be dramatic, with a marked drop in reading or face recognition.
Arteritic CRAO
Sudden profound vision loss with eye findings similar to other types, but caused by artery inflammation, most often due to giant cell arteritis. People may also have scalp tenderness, jaw pain when chewing, new headaches, or shoulder/hip aching. This type is an emergency because the other eye can be at risk.
Branch retinal artery occlusion
Only a portion of the retina loses blood flow, so vision loss may affect a wedge-shaped area or part of the visual field. Central vision can be normal if the macula is spared. Some may notice missing spots while reading or crossing the street rather than total blur.
Transient retinal ischemia
A brief blockage causes temporary vision loss (amaurosis fugax) that lasts minutes and then clears. Vision often returns to baseline, but this signals a high risk for a larger, permanent blockage. It should prompt urgent medical evaluation for stroke prevention.
CRAO with cilioretinal sparing
A separate small artery supplies the central retina in some people, which can preserve reading vision even when the main artery is blocked. Side vision is still typically very poor. Doctors sometimes classify symptoms as central vision–sparing versus central vision–threatening based on this pattern.
What genetics can tell you about symptoms
Certain inherited clotting variants, like Factor V Leiden or prothrombin G20210A, can raise the risk of a central retinal artery occlusion by making blood more likely to clot. Rare familial hypercholesterolemia variants can speed artery plaque buildup, narrowing the retinal artery and triggering sudden, painless vision loss.
Causes and risk factors
Common causes of central retinal artery occlusion include a blood clot that blocks the main artery to the eye. The clot often travels from a neck artery with plaque or from the heart, such as with an irregular heartbeat or a valve problem. Less often, giant cell arteritis, which is artery inflammation in older adults, or blood that clots too easily can cause it. High blood pressure, diabetes, high cholesterol, smoking, older age, carotid artery disease, and inherited clotting disorders all raise the risk of central retinal artery occlusion. Doctors distinguish between risk factors you can change and those you can’t.
Environmental and biological risk factors
When the main blood vessel feeding the retina becomes blocked, vision in one eye can dim or disappear quickly. Knowing what raises the chance of central retinal artery occlusion (CRAO) helps you and your care team move fast if vision changes suddenly. Because early symptoms of central retinal artery occlusion can be abrupt, understanding risks can guide faster action. Doctors often group risks into internal (biological) and external (environmental).
Arteries stiffen and narrow with age, making blockages more likely. This risk rises notably in later decades of life.
Plaque buildup in neck arteries can shed tiny clots that travel to the eye and block the central retinal artery. This is one of the most common sources of CRAO.
An irregular heartbeat can form clots in the heart that may break off and lodge in the retinal artery. Treating rhythm and clot risk lowers chances of CRAO.
Damaged or artificial valves can release small clots or debris into the bloodstream. These particles can travel upstream to the eye’s artery.
Genetic risk factors
Central retinal artery occlusion can sometimes be linked to inherited conditions that affect blood clotting, blood cells, or artery health. Carrying a genetic change doesn’t guarantee the condition will appear, but certain variants can raise the chance of a blockage in the eye’s main artery. Knowing about genetic risks can prompt faster action if early symptoms of central retinal artery occlusion occur, such as sudden, painless vision loss. These risks can matter more in younger adults or when there’s a strong family history.
Inherited thrombophilias: Changes like factor V Leiden or the prothrombin G20210A variant can tilt the blood toward clotting. This sometimes leads to artery blockages, including rare events in the retinal artery, especially at younger ages.
Protein C/S deficiency: These natural anticoagulants help keep clots in check. When inherited at low levels, the blood may clot more easily and raise the chance of a retinal artery blockage.
Antithrombin deficiency: Antithrombin normally dampens clot formation. A hereditary shortage can increase clot risk and, in uncommon cases, contribute to central retinal artery occlusion.
Homocystinuria: This rare genetic condition causes very high homocysteine, which can injure arteries and promote clots. It has been linked with retinal artery occlusion at young ages.
Sickle cell disease: Abnormal hemoglobin can make red blood cells stiff and sticky, reducing blood flow in small arteries. In rare instances, this can block the central retinal artery and cause sudden vision loss.
Familial hypercholesterolemia: This inherited condition raises LDL cholesterol from birth and speeds up artery build-up. Pieces of plaque can break off and lodge in the retinal artery, causing a blockage.
Elevated lipoprotein(a): Levels of lipoprotein(a) are mostly set by genes and can drive artery narrowing and clotting. High levels increase the chance of small cholesterol-rich particles breaking off and blocking the retinal artery.
Family history: Early strokes, heart attacks, or retinal artery occlusion in close relatives can suggest shared inherited risks. This pattern may point to an undiagnosed genetic clotting or cholesterol disorder.
Lifestyle risk factors
Central retinal artery occlusion is often linked to the same vascular processes that affect the heart and brain. Lifestyle choices can influence atherosclerosis, clotting tendency, blood pressure surges, and vessel spasms that raise the chance of a retinal artery blockage. Below are key lifestyle risk factors for Central retinal artery occlusion and how they may contribute to an event.
Toxins in smoke injure blood vessel linings and accelerate atherosclerosis. Smoking also increases platelet stickiness and clot formation that can block the retinal artery.
Diets high in saturated and trans fats, salt, and refined sugars promote plaque buildup and higher blood pressure. This raises the chance of a cholesterol or clot fragment obstructing the central retinal artery.
Low activity worsens cholesterol, blood pressure, and endothelial function. Regular aerobic and strength activity supports healthier arteries and reduces clotting tendency that could lead to occlusion.
Binge or heavy drinking can spike blood pressure and disturb clotting systems. These changes can trigger vessel injury or thrombosis that blocks the retinal artery.
Risk prevention
Central retinal artery occlusion is often linked to the same artery and heart risks that cause strokes. Lowering those risks—especially high blood pressure, cholesterol, diabetes, smoking, and irregular heart rhythms—can help protect vision. Prevention works best when combined with regular check-ups. Learn the early symptoms of central retinal artery occlusion—sudden, painless vision loss in one eye—and seek emergency care right away, since fast treatment may save sight even if it doesn’t prevent the event itself.
Keep blood pressure in a healthy range to reduce artery damage and clots. Home checks and regular clinic visits help catch changes early.
Lowering LDL (“bad”) cholesterol reduces fatty build‑up in neck and eye arteries. Diet changes and statin medication, if prescribed, can lower the chance of CRAO.
Smoking injures blood vessels and speeds plaque build‑up. Quitting lowers stroke and CRAO risk within months and keeps improving over time.
Irregular heart rhythms can form clots that travel to the eye. Treatment and blood thinners, when advised, lower the risk of CRAO and stroke.
Transmission
People often ask if central retinal artery occlusion is contagious; it is not. It doesn’t spread between people and there is no transmission route through touch, air, food, or blood. Central retinal artery occlusion happens when the artery feeding the retina is suddenly blocked, usually by a small clot or cholesterol plaque that traveled from the neck or the heart. It also isn’t typically inherited, though family traits like a tendency to form clots or very high cholesterol can increase someone’s risk. You can’t “catch” central retinal artery occlusion, but managing blood pressure, cholesterol, diabetes, and heart rhythm problems can lower the chance of it occurring.
When to test your genes
Central retinal artery occlusion is usually not genetic, so routine genetic testing isn’t needed for most people. Consider testing only if you have early-onset or recurrent arterial blockages, a strong family history of thrombophilia or premature strokes/heart attacks, or features suggesting inherited clotting disorders. Discuss with an ophthalmologist and a genetics-informed clinician to tailor care.
Diagnosis
Sudden, painless vision loss in one eye often leads people to urgent care within minutes or hours. These first clues guide the eye exam and immediate testing to confirm or exclude central retinal artery occlusion. From here, the focus shifts to confirming or ruling out possible causes. Your care team will use several targeted tests, and the diagnosis of central retinal artery occlusion is paired with a fast stroke evaluation because the eye and brain share the same circulation.
Clinicians ask exactly when vision changed and whether it was complete or partial. The timing helps distinguish CRAO from other causes and guides urgent treatment windows.
Visual acuity and side-vision checks show how much sight is affected. These results also help track changes over time and response to treatment.
A light test can show a weaker response in the affected eye, called a relative afferent pupillary defect. This supports an inner-retina problem like CRAO.
With special drops and lenses, the doctor looks for a pale retina with a cherry-red spot and thin, thread-like arteries. These classic features strongly suggest CRAO.
Stages of Central retinal artery occlusion
Central retinal artery occlusion does not have defined progression stages. It’s an acute blockage that causes sudden vision loss, so changes tend to happen quickly rather than step by step, though severity can vary depending on how complete the blockage is and how fast treatment starts. Different tests may be suggested to help confirm the diagnosis and look for the source of the blockage. Doctors typically diagnose CRAO with an urgent eye exam and imaging, and may also check the heart and neck arteries; knowing the early symptoms of central retinal artery occlusion—sudden, painless loss of vision in one eye—can help you seek care right away.
Outlook and prognosis
Sudden vision loss from central retinal artery occlusion can feel frightening, especially when it arrives without warning during a normal morning routine or while reading a text. Even though it can feel overwhelming, getting urgent care within hours offers the best chance to rescue some vision. The main risk is permanent central vision loss in the affected eye; some people are left with only peripheral “islands” or light perception, while others regain limited reading vision. The outlook is not the same for everyone, but early steps—calling emergency services, rapid eye assessment, and stroke evaluation—can change the trajectory.
Understanding the prognosis can guide planning and lifestyle changes. Most vision recovery, if it happens, occurs in the first days to weeks after central retinal artery occlusion, and late improvement is less common. CRAO is strongly linked to the same vascular risks as stroke and heart disease, so the longer-term health risk isn’t just about eyesight. Mortality is higher than average over the next few years because CRAO signals plaque or clotting problems; managing blood pressure, cholesterol, diabetes, and smoking can lower the chance of another event. People living with central retinal artery occlusion also face an increased risk of a brain stroke, especially in the first days to weeks, which is why urgent stroke-style workup is standard.
Some people experience partial vision return, while others notice stable but severe loss; both patterns are possible even with the same initial severity. Early symptoms of central retinal artery occlusion such as painless, sudden darkness in one eye, a curtain-like shadow, or brief “gray-outs” called amaurosis are reasons to seek emergency care. With ongoing care, many people maintain independence by adapting lighting, using magnifiers or large-print devices, and learning scanning strategies for mobility. Talk with your doctor about what your personal outlook might look like, including your eye’s chances of visual recovery and your overall cardiovascular risk.
Long-term effects
Central retinal artery occlusion is an eye emergency that can leave lasting changes in vision, even after urgent care. Recognizing early symptoms of central retinal artery occlusion and getting emergency treatment may improve immediate options, but many long-term effects persist. Long-term effects vary widely, and depend on whether any blood flow remained to the center of the retina. Some people stabilize within weeks, while others face later complications tied to blood vessel growth or cardiovascular risks.
Many affected eyes have permanent loss of sight, often severe and central. Some retain small islands of peripheral vision that help with orientation.
Patchy or missing areas of vision can persist after central retinal artery occlusion. This can make steps, curbs, or crossing streets harder to judge.
Fine-detail vision often stays limited, especially for reading small print or recognizing faces at a distance. Improvements after the first weeks are uncommon.
Seeing in low contrast remains difficult, such as gray text on a gray background or faces in dim rooms. This can affect safety in low light.
How is it to live with Central retinal artery occlusion?
Living with central retinal artery occlusion often feels like life split into “before and after,” because vision loss in one eye usually happens suddenly and can be permanent. Daily routines may need quick adjustments—larger-print devices, high-contrast lighting, mobility planning, and avoiding depth-perception hazards like curbs or pouring hot liquids—while medical follow-up focuses on stroke prevention and managing cardiovascular risks. Many find that work, driving, and hobbies requiring fine detail or fast hand‑eye coordination become harder, and they lean more on family or friends for rides, reading small text, or navigating unfamiliar places. For loved ones, the biggest shifts are practical support and patience during rehabilitation, along with shared vigilance for warning signs of stroke and encouragement to keep up with heart-healthy habits.
Treatment and drugs
Treatment for central retinal artery occlusion (CRAO) focuses on urgent steps to try to restore blood flow to the retina and protect the other eye and the heart and brain from related risks. If you reach emergency care within minutes to a few hours, doctors may try measures such as breathing high-flow oxygen (sometimes hyperbaric oxygen), eye-pressure–lowering drops or medication, gentle ocular massage, and in select cases clot-busting therapy; benefits are time‑sensitive and not guaranteed. Doctors also quickly look for and treat the cause—often a clot or plaque from the neck arteries or heart—using blood-thinning medicines, cholesterol and blood pressure control, diabetes management, and sometimes procedures on the carotid artery. Treatment plans often combine several approaches, and you’ll usually be referred to both an eye specialist and a stroke team for coordinated care and prevention. Ask your doctor about the best starting point for you, especially if you notice sudden, painless vision loss, which is treated as an eye stroke.
Non-drug treatment
Central retinal artery occlusion is an eye emergency where minutes matter. Recognizing early symptoms of central retinal artery occlusion—sudden, painless loss of vision in one eye—and getting urgent care gives the best chance of saving sight. Alongside medicines, non-drug therapies can be used in the first hours and later to protect vision and reduce future risk. What’s offered depends on timing, the cause, and your overall health.
Gentle, rapid pressure-and-release on the closed eye may help dislodge a blockage in the artery. This is sometimes attempted immediately while awaiting specialist care.
An eye specialist may release a tiny amount of fluid from the front of the eye to quickly lower pressure. Lowering pressure can improve blood flow to the retina in the critical early window.
Breathing oxygen in a pressurized chamber can deliver more oxygen to the retina while the artery is blocked. It may help if started as soon as possible, ideally within hours of vision loss.
If a severe neck-artery narrowing is found, surgery to clear the blockage can reduce the chance of another embolus reaching the eye or brain. This is a preventive step decided with a vascular surgeon after imaging.
Your genes may have an impact on how drugs work for you
Medications and procedures for central retinal artery occlusion can be affected by small genetic differences that change how your body handles clot-busting drugs, blood thinners, and pressure-lowering agents. These variants may influence effectiveness or bleeding risk, guiding doctors toward safer, better‑matched choices.
Pharmacological treatments
When early symptoms of central retinal artery occlusion appear, drug therapy is aimed at two goals: restoring blood flow quickly and lowering stroke risk afterward. In the first hours, doctors may use medicines to rapidly lower eye pressure or, in select cases, to dissolve a suspected clot. Sometimes medicines are taken short-term (acute treatment), while others are used long-term (maintenance therapy). Choices depend on timing, your overall health, and what likely caused the blockage.
This pill or IV medicine lowers eye pressure within minutes to try to improve blood flow to the retina. It is often given right away in the emergency setting for central retinal artery occlusion. People with severe kidney problems or a sulfa allergy may not be able to take it.
These beta-blocker eye drops reduce pressure inside the eye to support retinal perfusion. They are commonly used alongside other urgent measures for CRAO. People with asthma or slow heart rate may need a different option.
This IV diuretic draws fluid out of the eye and lowers pressure rapidly. It is used in hospitals when strong, fast pressure reduction is needed. Kidney function and fluid balance are checked closely during treatment.
This clot-busting drug may be used within a short time window in select patients to try to reopen the blocked artery. It can be given through a vein or directly into the artery at specialized centers, usually within hours of onset. Because it carries a bleeding risk, stroke and eye specialists decide case by case.
Genetic influences
For most people, central retinal artery occlusion is tied to cardiovascular factors—such as build-up in the neck arteries or heart rhythm issues—rather than a single inherited disorder. It’s natural to ask whether family history plays a role. Genes can still matter indirectly: inherited conditions that raise clotting or cholesterol can increase the chance of a blockage, especially at younger ages. Examples include familial hypercholesterolemia or very high lipoprotein(a), a cholesterol particle that speeds artery build-up; clotting tendencies such as factor V Leiden, and conditions like sickle cell disease or trait, can also raise risk in some people. Because early symptoms of central retinal artery occlusion are sudden, painless vision loss, doctors focus first on urgent treatment and stroke and heart evaluations. Genetic testing is considered mainly when this condition occurs without typical risk factors or at a young age. If several relatives have had early stroke, blood clots, or very high cholesterol, sharing that history can help your team decide whether to check for inherited risks.
Is Central retinal artery occlusion genetic?
Genetics plays a limited role in central retinal artery occlusion; most cases relate to cardiovascular risk factors like atherosclerosis or emboli. Rarely, inherited clotting tendencies or lipid disorders raise risk. Family history matters mainly through shared blood pressure, cholesterol, or diabetes patterns.
Pharmacogenetics—how genetics influence drug effects
After emergency care for central retinal artery occlusion, many people are started on medicines to lower the chance of another event, much like stroke prevention. Genes can influence how well some of these medicines work; for example, the body needs certain enzymes to turn clopidogrel into its active form, and some people process it too slowly to get full benefit. Genetic testing can sometimes identify how your body handles clopidogrel, helping your care team choose a different antiplatelet, such as ticagrelor, when appropriate. If the cause is a heart rhythm issue and warfarin is prescribed, common genetic differences can affect the safest dose, so testing may support a safer starting dose while the clinic adjusts it. For cholesterol-lowering statins used after a vascular event, a common gene difference can raise the chance of muscle side effects, so a different statin or dose may be considered. Your genes are just one piece of the puzzle—age, kidney and liver function, and other medicines also shape drug response—so genetic test results are used alongside your overall health to guide the treatment of central retinal artery occlusion.
Interactions with other conditions
Central retinal artery occlusion often occurs alongside cardiovascular issues like carotid artery disease, atrial fibrillation, high blood pressure, and diabetes, because the same circulation problems can send clots or narrow the vessels that feed the eye. Doctors call it a “comorbidity” when two conditions occur together. Recognizing early symptoms of central retinal artery occlusion—sudden, painless vision loss in one eye—matters because it can signal a higher short‑term risk of stroke or even heart attack. In people over 50, giant cell arteritis (also called temporal arteritis) can trigger central retinal artery occlusion and demands urgent treatment to protect the other eye and overall health. Blood disorders that thicken or clump the blood, such as sickle cell disease or certain clotting tendencies, and eye problems that reduce blood flow can raise the chance of the condition or make recovery harder. Because interactions vary from person to person, coordinated care between your eye specialist, a stroke team, and your primary doctor helps find clot sources, manage risk factors, and adjust medications so treatment for one problem doesn’t make another worse.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described sudden, painless loss of sight in one eye that arrived “like a curtain,” then left lasting blur or darkness. Family doctors and eye specialists wrote about these abrupt vision attacks long before imaging existed, noting a normal-feeling eye that nonetheless couldn’t see. Some accounts mentioned a brief flicker of dimming beforehand, especially while reading or walking outside, then a sharp drop in vision that didn’t improve with rest.
First described in the medical literature as a blockage in the main artery to the retina, Central retinal artery occlusion gradually moved from a bedside observation to a clearly defined emergency. Early clinicians relied on what they could see with a handheld lens: a very pale retina and a small red spot at the center. Before that hallmark look was widely recognized, episodes were sometimes mistaken for migraine aura or inflammation. As medical tools improved, the pattern became clearer—sudden vision loss in one eye in older adults, often alongside high blood pressure, heart disease, or cholesterol problems.
From early theories to modern research, the story of Central retinal artery occlusion tracks with advances in heart and brain care. When doctors learned how cholesterol plaques and clots travel from the neck or heart to the eye, the condition was linked to stroke pathways. That shifted thinking: a blocked eye artery wasn’t just an eye problem, it was part of the same system that can cause a stroke. This led to a new urgency around timing, recognizing early symptoms of Central retinal artery occlusion, and checking the carotid arteries and heart rhythm.
With fluorescein dye studies in the mid-20th century and, later, optical coherence tomography, clinicians could watch blood flow stall and the retina swell in real time. These imaging tools confirmed what earlier generations suspected and helped separate similar conditions, such as branch artery blockages and vein occlusions. Over time, descriptions became more precise, including transient episodes that resolved within minutes (amaurosis fugax) and full occlusions that caused lasting vision loss.
In recent decades, awareness has grown that Central retinal artery occlusion is an ocular stroke and should trigger the same rapid response used for brain strokes. Stroke teams, carotid imaging, heart monitoring, and careful control of blood pressure and cholesterol became routine parts of care. Researchers also documented differences across ages and causes—such as inflammatory artery disease in some older adults and clotting disorders in a smaller group of younger people—while keeping the core message consistent: quick recognition matters.
Knowing the condition’s history explains today’s approach. What began as careful observation of a sudden, silent loss of sight built the foundation for modern protocols that treat the eye and protect the brain and heart.